drugset / Trial / NCT06357520

A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants

NCT06357520

Phase 1 Completed 14 enrolled AstraZeneca
NaSingle-groupOpen-labelOther

Summary

The main purpose of this study is to assess the effect of itraconazole on the pharmacokinetic (PK) of baxdrostat.

Timeline

Start
2024-04-16
Primary completion
2024-06-17
Completion
2024-06-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Baxdrostat Small molecule Oral
Subject Itraconazole Small molecule Oral

Indications

No indication recorded.